Abstracts deadline Friday 24 April 2026! Submit now
Abstracts deadline EXTENDED Friday 22 May 2026! Submit now
In Vivo CAR-T: The Next Standard of Care for Autoimmune Disease? Synopsis:Coming soon. Agenda – Thursday 29 October Workshop chairperson: TBC Presentation title TBA Prof Georg Schett, Germany Presentation title TBA Prof Cameron Turtle, Australia
Synopsis: This interactive workshop explores the practical use of generative artificial intelligence (GenAI) in rheumatology, with a strong focus on critical thinking, safety, and real-world applicability. Moving beyond the hype, the session will equip participants with the skills to integrate AI tools into clinical, academic, and educational workflows in a rigorous and responsible manner.Through a combination of guided discussions and hands-on exercises, participants will gain experience in applying structured prompting techniques and verification frameworks to improve the quality and reliability
We are excited to announce the release of new videos on the APLAR Congress website. These videos provide updates on the upcoming congress and initiatives from the APLAR cohort. The videos feature messages from various members of the APLAR community, including Prof Tsutomu Takeuchi, Immediate Past President of APLAR and Prof Lai-Shan Tam, President-Elect of APLAR, including many others. Each video offers unique insights and updates about the congress, making them a must-watch for anyone interested in the event. The
We have noticed fraudulent activity from unsupported accommodation providers contacting delegates and speakers to book your accommodation at APLAR Congress. These companies are not supported by APLAR or the congress organisers. If you have been contacted directly to book accommodation, please do not engage, or proceed with booking your hotel. All accommodation bookings can be made with the APLAR congress secretariat via info@aplarcongress.com or directly through the website: https://aplarcongress.com/accommodation/ Please report any suspicious accommodation communications to info@aplarcongress.com
The early bird registration deadline for APLAR 2026 has been extended until 23 June 2026 at 11:59PM — don’t miss your chance to be part of the region’s premier rheumatology event. Join us for five days of world-class speakers, interactive sessions, and unmissable networking opportunities.
Title coming soon. Objectives: Information coming soon. Agenda – Friday 30 October Chairperson: TBC
APLAR Travel Grant Invitation The Asia Pacific League of Associations for Rheumatology (APLAR) cordially invites APLAR Young Rheumatologists (AYR) to apply for the APLAR Congress Travel Grant to attend the APLAR Congress in Seoul, Republic of Korea, from 28 October – 1 November 2026. APLAR will award 50 need-based travel stipends to AYR members who have an accepted abstract for a poster, oral, or rapid-fire presentation at the APLAR Congress 2026. The grant assists AYR in covering part of the
Due to strong interest, the abstract submission deadline for APLAR 2026 has been extended to 22 May 2026, providing additional time for authors to prepare and submit their work. This extension represents the final opportunity to be considered for inclusion in the APLAR 2026 scientific program. Please note that APLAR will not offer late abstract submissions this year. We encourage all prospective authors to take advantage of the extended deadline and submit their abstracts before submissions close. Presenting at APLAR
Latest Evidence on Methotrexate and JAK Inhibitors Objectives: This session will discuss the combination therapy of JAK inhibitors with MTX and JAK inhibitors monotherapy. Agenda – Saturday 31 October Chairperson: Dr Seong-Ho Kim, Republic of Korea 1730-1825 Latest Evidence on Methotrexate and JAK Inhibitors Prof Yuko Kaneko, Japan
Polymyalgia Rheumatica: From Diagnosis to Long-Term Disease Control – Current Recommendations and Unmet Needs Objectives: Polymyalgia rheumatica (PMR) is a common inflammatory rheumatic disease affecting adults aged 50 years and older, characterized by bilateral pain and stiffness in the shoulder and pelvic girdles and a substantial impact on physical function and quality of life. Despite its relatively high prevalence, PMR remains a challenging condition due to heterogeneous clinical presentation, frequent diagnostic uncertainty, and a chronic or relapsing disease course in
Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
